The Experts below are selected from a list of 4446 Experts worldwide ranked by ideXlab platform

Kate A Scannell - One of the best experts on this subject based on the ideXlab platform.

Morgan Rice - One of the best experts on this subject based on the ideXlab platform.

Victoria Ballen - One of the best experts on this subject based on the ideXlab platform.

  • Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Colombia
    Renal Replacement Therapy, 2017
    Co-Authors: José Lucas Daza, Yaroslad De La Cruz, Jesús Morales, Carolina Molina, Mauricio Duque, Ingrid Prieto, Victoria Ballen
    Abstract:

    In the present report case, we show a peritonitis infection in a continuous ambulatory peritoneal dialysis (CAPD) patient in Colombia. We isolated Rhodococcus equi in the peritoneal fluid culture. Rhodococcus equi is a rare pathogen in immunocompetent people. Rhodococcal peritonitis complicating CAPD has only been reported in few cases, and experience in its treatment is limited. Antimicrobial treatment is unsuccessful because of the virulence and resistance of the Rhodococcus equi. So, the removal of the catheter determines the clinical resolution in most of the cases. In our case, we present the resolution with a combined antibiotic therapy. We present the case of a 50-year-old female patient with chronic kidney disease secondary to diabetic nephropathy. The patient reported to our unit with abdominal pain 6 months after the start of the treatment with CAPD. An intraperitoneal empirical antibiotic scheme was initiated according to the guidelines of the International Society for Peritoneal Dialysis. Patient denies contact with farm animals in her daily life. After 7 days of treatment, Rhodococcus equi was found in the culture. It was decided to extrapolate antibiotic regimen based on the studies of immunocompromised patients suffering from pulmonary infections. The removal of the peritoneal dialysis catheter is decided, but the patient refuses to undertake the procedure. The patient progresses without abdominal pain, and the antibiotic treatment is changed by azithromycin 500 mg daily and performing peritoneal dialysis in CAPD mode. This case, like the previously published ones, highlights the limitations in the treatment of Rhodococcus equi due to the limited number of reported cases of this pathogen and the absence of standard treatment protocols leading to variable response rates. The therapeutic resolution was due to the prolonged use of antibiotic treatment and being aware of the potential increase of the morbidity.

  • Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Colombia
    BMC, 2017
    Co-Authors: José Lucas Daza, Yaroslad De La Cruz, Jesús Morales, Carolina Molina, Mauricio Duque, Ingrid Prieto, Victoria Ballen
    Abstract:

    Abstract Background In the present report case, we show a peritonitis infection in a continuous ambulatory peritoneal dialysis (CAPD) patient in Colombia. We isolated Rhodococcus equi in the peritoneal fluid culture. Rhodococcus equi is a rare pathogen in immunocompetent people. Rhodococcal peritonitis complicating CAPD has only been reported in few cases, and experience in its treatment is limited. Antimicrobial treatment is unsuccessful because of the virulence and resistance of the Rhodococcus equi. So, the removal of the catheter determines the clinical resolution in most of the cases. In our case, we present the resolution with a combined antibiotic therapy. Case presentation We present the case of a 50-year-old female patient with chronic kidney disease secondary to diabetic nephropathy. The patient reported to our unit with abdominal pain 6 months after the start of the treatment with CAPD. An intraperitoneal empirical antibiotic scheme was initiated according to the guidelines of the International Society for Peritoneal Dialysis. Patient denies contact with farm animals in her daily life. After 7 days of treatment, Rhodococcus equi was found in the culture. It was decided to extrapolate antibiotic regimen based on the studies of immunocompromised patients suffering from pulmonary infections. The removal of the peritoneal dialysis catheter is decided, but the patient refuses to undertake the procedure. The patient progresses without abdominal pain, and the antibiotic treatment is changed by azithromycin 500 mg daily and performing peritoneal dialysis in CAPD mode. Conclusions This case, like the previously published ones, highlights the limitations in the treatment of Rhodococcus equi due to the limited number of reported cases of this pathogen and the absence of standard treatment protocols leading to variable response rates. The therapeutic resolution was due to the prolonged use of antibiotic treatment and being aware of the potential increase of the morbidity

Howard I Finkle - One of the best experts on this subject based on the ideXlab platform.

Edward J Portoni - One of the best experts on this subject based on the ideXlab platform.